Trial Profile
A phase I trial of cetuximab (C225) and pemetrexed with concurrent radiation in head and neck cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2013
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Pemetrexed (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 08 Apr 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.